Five-Year Analysis Shows Immunotherapy Plus Chemotherapy Before Lung Cancer Surgery Significantly Improves Long-Term Survival
June 04, 2025
June 04, 2025
BALTIMORE, Maryland, June 4 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
* * *
Five-Year Analysis Shows Immunotherapy Plus Chemotherapy Before Lung Cancer Surgery Significantly Improves Long-Term Survival
Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer (NSCLC) -- the leading cause of cancer deaths worldwide -- improved long-term survival overall compared with chemotherapy alo . . .
* * *
Five-Year Analysis Shows Immunotherapy Plus Chemotherapy Before Lung Cancer Surgery Significantly Improves Long-Term Survival
Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer (NSCLC) -- the leading cause of cancer deaths worldwide -- improved long-term survival overall compared with chemotherapy alo . . .